PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSIS
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.892
https://www.valueinhealthjournal.com/article/S1098-3015(11)01031-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
365
First Page :
A160
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01031-X&doi=10.1016/j.jval.2011.02.892